Skip to main content
    G

    Greenwich Lifesciences Inc (GLSI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $18.70
    +4.94 (+35.90%)

    Market Cap: $201.97M

    Last updated: Nov 17, 2026 at 4:41 PM ET

    Greenwich Lifesciences Inc (GLSI) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Greenwich Lifesciences (GLSI) has a latest price of $18.70 on Nov 17, 2026, 45.2% below its 52-week high of $34.10. Its price rose 124.8% over the past 12 months. The month-end price fell 50.8% over the 5 years through Oct 2026, a compound annual decline of 13.2%.

    Price Chart

    From Sep 2020 to Oct 2026, its highest month-end close was $44.94 in Jun 2021 and its lowest $3.51 in Oct 2020, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart GLSI with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GLSI.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 7.8%, and over 6 months it fell 28.9%. The month-end price rose 108.3% over the 3 years through Oct 2026, a compound annual rate of 27.7%.

    PeriodChange
    1 month+22.9%
    3 months+7.8%
    6 months-28.9%
    12 months+124.8%
    12 months, with dividends+124.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+108.3%+27.7%
    5 years-50.8%-13.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 87.1%, and its weakest was 2022, when it fell 37.5%.

    YearCloseChange
    2026 through Oct 2026$17.41-17.1%
    2025$21.01+87.1%
    2024$11.23+6.7%
    2023$10.52-30.8%
    2022$15.20-37.5%
    2021$24.33-33.3%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 12.8% above its 50-day average of $16.58 and 10.3% below its 200-day average of $20.84.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$18.70
    52-week high$34.10-45.2%
    52-week low$7.78+140.4%
    50-day average$16.58+12.8%
    200-day average$20.84-10.3%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 61.9%.

    MeasureValue
    1-year beta3.12
    Largest fall, 1 year-61.9%
    Largest fall, 3 years-61.9%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About GLSI

    What is GLSI's 1-year price change?

    Greenwich Lifesciences's price rose 124.8% over the past 12 months. With dividends included, the 12-month total return was 124.8%.

    What is GLSI's 5-year price change?

    Greenwich Lifesciences's month-end price fell 50.8% over the 5 years through Oct 2026, a compound annual decline of 13.2%. These figures leave out dividends.

    What is GLSI's 52-week high and low?

    Greenwich Lifesciences's 52-week high is $34.10 and its 52-week low is $7.78. Its latest price of $18.70 on Nov 17, 2026 is 45.2% below the high.

    What is GLSI's beta?

    Greenwich Lifesciences's 1-year beta against the S&P 500 is 3.12, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 61.9%.

    Is the GLSI chart free?

    Yes. Advanced Charting for GLSI is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.